COVID-19: EU Commission authorises second adapted vaccine for Member States
The European Medicines Agency (EMA) carried out a stringent evaluation of the vaccine under the accelerated assessment mechanism. Following this evaluation, the…
European Health Union: EU Commission authorises first vaccine to protect infants from RSV infections
The Commission has authorised Abrysvo, the first vaccine to protect older adults and infants up to six months of age…
UK: England announces precautionary measures to improve Covid surveillance
London, 30 December 2022 England joins a growing list of countries across the world to...
COVID-19: EU Commission authorises seventh safe and effective vaccine
Brussels, 11 November 2022 The Commission granted a marketing authorisation as a booster dose for...
Joint Statement by EU Commissioner Kyriakides, WHO Regional Director for Europe and ECDC Director on COVID-19 and influenza vaccinations for this winter
Brussels, 12 October 2022 “Although we are not where we were one year ago, it...
Speech by Ursula von der Leyen at the 2022 Bill & Melinda Gates Foundation awards
Brussels, 21 September 2022 “Check against delivery” Dear Melinda, dear Bill, Distinguished guests, Thank you...
Monkeypox outbreak: HERA secures additional vaccine doses
Brussels, 7 September 2022 Today, HERA, the Commission’s Health Emergency Preparedness and Response Authority, has secured an additional...
EU Commissioner Kyriakides on the intradermal use of monkeypox vaccine
Brussels, 19 August 2022 Today, the European Medicines Agency (EMA) has advised on intradermal use of monkeypox...
Teleconference: Press briefing by White House Monkeypox Response Team and Public Health Officials
Washington D.C., 11 August 2022 FENTON: Hi, I’m Bob Fenton, the White House National Response...
Withdrawal by CureVac of vaccine candidate – EU Commission answer
Brussels, 25 July 2022 See question(s) : E-001822/2022 EN E-001822/2022 Answer given by Ms Kyriakides on...
WTO analytical review of COVID-19 Vaccines Patent Landscape (VaxPaL)
10 February 2022 – Innovation and patenting activities of COVID-19 vaccines in WTO members: Analytical...